Trials / Completed
CompletedNCT00215410
Study in Patients With Asthma
- Status
- Completed
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 36 (planned)
- Sponsor
- Dey · Industry
- Sex
- All
- Age
- 5 Years – 12 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to determine the most safe and effective dose of the investigational drug in comparison with a control drug and placebo.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Formoterol Fumarate |
Timeline
- Primary completion
- 2003-10-01
- Completion
- 2005-10-01
- First posted
- 2005-09-22
- Last updated
- 2010-11-11
Locations
12 sites across 1 country: United States
Source: ClinicalTrials.gov record NCT00215410. Inclusion in this directory is not an endorsement.